Clinical trial registry record

Evaluation of the Efficacy and Tolerability of Autologous Adipose Tissue Derived Stem Cells on Facial Rejuvenation

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated September 30, 2019.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT03928444
Last registry update
September 30, 2019
Status
Completed
Phase
Phase not reported
Sponsor
Alexandria University
Enrollment
15
Countries
Egypt
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · TREATMENT · NONE
Evidence population
Human clinical study registration
Participants
15
Population
FEMALE · 35 Years
Duration
2019-01-01 to 2019-08-06
Intervention
intradermal injection of adipose derived stem cells to one side of the face; intradermal injection of saline to one side of the face
Comparator
control
Outcomes measured
Assessment of the degree of aesthetic improvement using the global aesthetic improvement scale GAIS 5-point scale where…; Assessment of trans-epidermal water loss (TEWL) in gm /h-m2 using noninvasive probe (Dermal measurement system EDS12, U…; Assessment of skin hydration in units using noninvasive probe (Dermal measurement system EDS12, UK) on both temple regi…; Measurement of epidermal thickness in mm using UBM (Ultrasound Bio microscopy) on both temple regions of the head — 6 m…; Measurement of dermal thickness in mm using UBM (Ultrasound Bio microscopy) on both temple regions of the head — 6 mont…; A visual analog scale, will be used to assess participants' satisfaction by the treatment and side effects — 6 months
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Stem cells · 100%Title contains controlled term: stem cell. Abstract contains controlled term: stem cell. Source terminology contains: stem cell. Title supplies longevity context: rejuvenation. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

stem cells
Open primary sourceExport JSON